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Abstract
Rationale: Acute atherothrombotic occlusion in heart attack and stroke implies disruption of the vascular endothelial barrier
that exposes a highly procoagulant intimal milieu. However, the evolution, severity, and pathophysiological consequences
of vascular barrier damage in atherosclerotic plaque remain unknown, in part because quantifiable methods and
experimental models are lacking for its in vivo assessment.
Objective: To develop quantitative nondestructive methodologies and models for detecting vascular barrier disruption in
advanced plaques.
Methods and Results: Sustained hypercholesterolemia in New Zealand White (NZW) rabbits for .7–14 months engendered
endothelial barrier disruption that was evident from massive and rapid passive penetration and intimal trapping of
perfluorocarbon-core nanoparticles (PFC-NP: ,250 nm diameter) after in vivo circulation for as little as 1 hour. Only older
plaques (.7 mo), but not younger plaques (,3 mo) demonstrated the marked enhancement of endothelial permeability to
these particles. Electron microscopy revealed a complex of subintimal spongiform channels associated with endothelial
apoptosis, superficial erosions, and surface-penetrating cholesterol crystals. Fluorine (
19F) magnetic resonance imaging and
spectroscopy (MRI/MRS) enabled absolute quantification (in nanoMolar) of the passive permeation of PFC-NP into the
disrupted vascular lesions by sensing the unique spectral signatures from the fluorine core of plaque-bound PFC-NP.
Conclusions: The application of semipermeant nanoparticles reveals the presence of profound barrier disruption in later
stage plaques and focuses attention on the disrupted endothelium as a potential contributor to plaque vulnerability. The
response to sustained high cholesterol levels yields a progressive deterioration of the vascular barrier that can be quantified
with fluorine MRI/MRS of passively permeable nanostructures. The possibility of plaque classification based on the metric of
endothelial permeability to nanoparticles is suggested.
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Introduction
The atherothrombotic syndromes of coronary heart disease,
ischemic stroke and peripheral artery disease together account for
22% of all deaths worldwide (2004), with a prevalence of 26 million
cases in the USA alone commanding a cost of greater than $4
billion/yr (2006) [1]. The cause of acute vascular syndromes is
attributable to rupture of the thin cap overlying an inflamed, fatty
atherosclerotic plaque in 2/3 of cases, and to endothelial ‘‘erosions’’
in the rest [2,3,4,5]. In either case, the normally restrictive vascular
barrier function is disturbed as a consequence of inflammatory
cellular infiltrates, reactive oxygen species, and growth factors that
result in enhanced local permeability, inflammatory cell transcy-
tosis, and thrombogenicity [6,7,8,9,10,11,12]. In the early stages of
the process, enhanced endothelial penetration and retention of
lipoproteins has been hypothesized to incite inflammatory events
that lead to plaque progression in a process that proceeds by years
any clinical presentation [13]. However, the evolution and ultimate
severity of endothelial permeability in response to long-term
hypercholesterolemia has not been elucidated in experimental
models or clinical subjects.
The focal pathophysiological features that mark the evolution of
late stage barrier disruption remain uncertain as a consequence of
the lack of well accepted and robust experimental models that
suitably represent the complexity of endothelial barrier disruption
[14], and the lack of specific nondestructive diagnostic techniques
that can quantify lesion severity. Acute experimental models of
lipotoxic stress have been developed that elicit endothelial cell
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8apoptosis as a precursor to vascular barrier disruption [15,16].
Increased endothelial permeability is an early preclinical feature of
barrier dysfunction and has been studied with the use of tracer
agents (,5 nanometers) such as horse radish peroxidase,
radiolabeled albumin, or various permeable dyes [7,17]. Over
time, endothelial cell senescence ensues, leading to local
inflammatory responses, compromised endothelial regenerative
potential, and ultimately apoptosis and endothelial denudation
[18,19,20,21,22]. Yet the aforementioned methods for studying
endothelial function do not specifically depict barrier disruption in
vitro or in vivo because they generally reflect paracellular leakage in
early stages of disease, as distinguished from later stage endothelial
disruptions (erosion, micro-tears, etc.) that might portend more
immediate clinical consequences.
To develop a methodology ultimately capable of longitudinally
delineating the severity of endothelial barrier disruption, we
propose a translatable diagnostic imaging approach based on the
use of semipermeant, diffusible PFC-NP [23,24,25] tracers that
might penetrate highly permeable late stage plaques. The fluorine
core of these nanostructures can be sensitively registered with the
use of magnetic resonance spectroscopy and imaging to provide a
unique diagnostic marker for leaky endothelial barriers. We
hypothesized that the larger dimension of these particles (,250
nanometer, nominal diameter), as compared with smaller
circulating lipoproteins known to penetrate and collect in lesions
at a very early stage [13], would manifest limited diffusion into
minimally diseased regions in early plaques that retain a relatively
intact vascular barrier, while enabling registration of more severe
endothelial disruption in advanced plaques.
The quest to develop a methodology that predicts plaque
behavior has occupied researchers for many years. Unfortunately,
new data from the multicenter PROSPECT trial mapping the
natural history of vascular events after initial presentation for acute
coronary syndromes indicate that single structural predictors such
as thin cap atheroma, plaque burden, or luminal stenosis suffer
poor specificity for predicting subsequent events over a 3.4 year
interval (,5–10%). Thus, these classic features of plaque behavior,
while seemingly necessary to establish the conditions for plaque
rupture, are not sufficient to classify risk in individual patients [26].
The image-based readouts proposed herein may enable for the
first time a quantitative description of the development of
unexpectedly severe endothelial permeability in advanced exper-
imental atherosclerosis and suggest a method for in vivo
interrogation of heretofore uncharacterized biophysical features
of advanced plaques according to a quantifiable functional
permeability metric rather than the structural readouts employed
in trials such as PROSPECT.
Results
Temporal evolution of vascular permeability
A synopsis of all animal experiments is tabulated in the
supplemental data (Table S1). Serum cholesterol levels measured
at baseline and periodically (every 1–3 months) increased from
1.4560.13 mg/dl to of an average of 27.3061.27 mg/dl for all
multiple samples for each rabbit. All 27 rabbits fed with high
cholesterol diet exhibited atherosclerotic plaques. The three
month diet rabbits exhibited minimal plaque protrusion and
thinner plaques overall, more prominent at expected branch
points, with no apparent vessel remodeling. Rabbits on diet for
more than 7 months exhibited more severe atherosclerotic lesions,
extending throughout the entire extent of the collected specimen
in 12 month diet animals, but regionally patchy in many cases with
less affected areas adjacent to severely affected ones (see Figure 1A
and C). We hypothesized that the semipermeant nanoparticles
illustrated in Figure 1B, which depicts the properties of the
fluorine nanoparticle contrast agent for imaging and spectroscopy
based on the unique
19F signals that emanate from the Crown
Ether (CE) core, would penetrate the raised plaques but not the
adjacent more normal appearing regions (Figure 1C top), or the
earlier 3 month old lesions.
For all rabbits beyond the 7 month feeding interval, massive
penetration and accumulation of trapped NP were observed in the
intimal regions of all plaques so treated, but few in the adventitia
and none apparent in the media, indicating in vivo penetration
from the luminal side. In the aorta samples, a spatially
heterogeneous distribution of plaques and particle accumulation
was observed, with no particles apparent in adjacent more normal
appearing intima in the same tissue sections (Figure 1C center/
bottom). As a further control, we also noted that nonfluorescent
nanoparticles produced no intimal optical signal in two samples
(Figure S1A, B), indicating the autofluorescence was not
confounding.
Cholesterol diet duration also influenced in vivo nanoparticle
penetration as shown by the very limited plaque and intimal
signals in rabbits fed cholesterol for only 3 months (Figure 2A)
versus more extended exposure times (Figure 2B, C), suggesting
the necessity for prolonged exposure to induce plaque growth and
significant endothelial barrier disruption. This very spotty and
limited plaque penetration at three months was characteristic of
the relatively preserved barrier function even in the presence of
slightly raised plaques as evidenced by the DAPI nuclear staining
of intimal thickening in Figure 2A. Again, grossly unaffected
regions did not accumulate nanoparticles at any time point.
A plot of fluorescence scores for all rabbits exposed to 2 (n=9)
or 6 (n=13) hour NP circulation (Figure 2D) illustrates the
temporal dependence of plaque permeability on the duration of
hypercholesterolemia. Because most experiments allowed in vivo
nanoparticle circulation for 2 or 6 hours, which manifested
statistically equivalent plaque penetration by ANOVA (p=0.28),
the fluorescence scores at these time points were plotted for all
rabbits at all feeding times and were fitted nicely to a sigmoidal
function (R
2=0.717) to illustrate the temporal progression of NP
penetration. An exponential fit also was statistically significant
(R
2=0.678). Furthermore, the lack of difference between 2 hour
and 6 hour circulation times for fluorescence scores attests to the
rapidity of the diffusion process. Limited samples for 1 (n=1), 12
(n=1), and 24 (n=1) hour circulating times indicated similarly
rapid nanoparticle trapping (data not shown).
Quantification of nanoparticle signal in plaque
To confirm the presence of intact nanoparticles in the intima after
in vivo circulation, coregistered fluorine (
19F) and proton (
1H)
magnetic resonance images acquired ex vivo at 11.7T revealed
abundant
19F signals emanating from the nanoparticle CE cores in
the intima of raised plaques but apparently absent from the
adjacent grossly normal regions, consistent with the prior
fluorescent images (Figure 3A, B). In 25 aortic segments from
16 rabbits with advanced lesions (.7 months feeding) a
quantifiable
19F MR spectrum was obtained resulting in an
average concentration of PFC-NP of 2.7860.93610
8/cm
2 across
the entire tissue slice (Figure 3C). On the contrary, in 9 segments
from four 3-month diet rabbits with less severe plaques,
significantly reduced permeation of PFC-NP was detected,
measuring only about 10% of that for the older plaques, or
0.2860.10610
8/cm
2 (p,0.0003).
For the
19F MR imaging, 12 segments from 10 rabbits
demonstrated heterogeneously distributed fluorine signals in areas
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(Figure S1C, D) that appeared grossly normal, irrespective of the
fluorescence signals (Figure S1A, B). These images (Figure S1A,
C) also indicate that the fluorescent signals originate from intact
nanoparticles since the
19F signals are present in the same areas
where fluorescence is positive, but not in adjacent grossly normal
regions (also Figure 3B).
Nanoparticle treated specimens could be identified from
fluorescence signals in intact whole mount preparations (Figure
S2A) that permitted further quantitative segmental analysis with
high resolution MRI/MRS (Figure S2B,C). As we have
demonstrated previously [27,28,29] the
19F CE spectral signatures
were collected along with a perfluorooctylbromide (PFOB)
reference signal (Figure S2B) to permit absolute quantification
of the concentration of tissue bound nanoparticles per voxel,
shown in Figure S2C as nanomolar color-coded particle concen-
trations. In this example the signal-to-noise for CE and PFOB in
the region-of-interest shown in Figure S2B was 29.7 dB and
26.2 dB respectively; and
19F CE signal integration revealed a
total volume of PFC-NP of 4.5 nanoliters, or 6.05610
8 particles in
the sample of 10 month diet rabbit. As shown in Figure S2C
right, these quantitative measures of tissue PFC-NP content also
may be expressed alternatively as moles of either PFC-NP or
19F
atoms, or as molar concentrations of either moiety.
Ex vivo confirmation of nanoparticle penetration through
disrupted endothelial barriers
To confirm that the nanoparticles entered the plaques rapidly
by passive diffusion, ex vivo incubations of atherosclerotic aorta
segments from two 9-month and five 12-month diet rabbits were
carried out in tissue culture supported with acellular media. Aortic
segments (n=19) exposed to fluorescent nanoparticles for 15 min,
30 min, 1, 2 or 6 hours, revealed rapid penetration and trapping
analogous to that observed for in vivo experiments (Figure 4A, B).
Figure 1. Rabbit aorta cholesterol plaque formation and NP diffusion into intima in vivo. A: Sudan IV staining (en face) of opened aorta
section showing plaque (red) in 12 month diet rabbit but seldom in 3 month diet rabbit. Sections were collected as labeled for fluorescence
microscopy and histology (1 cm), electron microscopy (0.5 cm), lower segments for MRI/MRS and whole mount fluorescence images (IVIS). B: Cartoon
of PFC-NP structure, and
19F MR spectroscopy (top left), TEM of NP (top right);
19F and
1H MR image of test tubes containing CE core NP showing
fluorine signatures (bottom) and oil core NP as control showing no signal. C: Top: En face Sudan IV staining of section with plaque (P: red) and grossly
normal (N: clear) areas. Mid: Marked fluorescent nanoparticle presence in plaque (P) intima (I) of 12 mo cholesterol diet rabbit aorta (green) after
12 hours in vivo circulation. Minimal staining of adventitia (A) is noted , and none apparent in media (M) or lumen (Lu). Bottom: Fluorescent NP
signals (green) in plaque intima (P), but not the adjacent grossly normal regions (N). Blue=DAPI nuclear stain.
doi:10.1371/journal.pone.0026385.g001
Endothelial Disruption in Advanced Aorta Plaque
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26385Examination of 4 aortic segments from one 3-month diet rabbit
undergoing ex vivo 2 and 6 hour nanoparticle incubations
confirmed the minimal penetration previously observed for
samples assessed after in vivo circulation (Figure 4C). MRI results
again corroborated the fluorescence microscopy readouts of
nanoparticle distributions (not shown). A plot of ‘‘fluorescence
scores’’ for ex vivo incubated aortas at all time points (Figure 4D)
illustrates the dependence of plaque permeability on the duration
of ex vivo exposure to PFC-NP. ANOVA revealed a temporal
dependence on fluorescence score (F=8.0, p,0.002). No
significant difference (p=0.78) was observed between 2 hour
and 6 hour in vitro treatment groups, consistent with the prior in
vivo exposure data (see above), although the one hour incubations
in this case were somewhat slower to particle diffusion (p=0.06).
These ex vivo incubations support the passive penetration
hypothesis because there is no flow through vasa vasorum to
transport the PFC-NP to the intima. Furthermore, the demon-
strated gradient for PFC-NP accumulation is from lumen to
intima, not from adventitia to intima.
Structural features of disrupted endothelial barriers in
rabbits
Histopathology: Adjacent sections were stained after fluorescent
signal were confirmed. Basic plaque morphology is shown on H&E
staining of a 12-month diet rabbit’s aorta (Figure S3A).
Traditional plaque constituents such as macrophages and foam
cells were abundant (Figure S3B). Oil Red O staining
demonstrated that lipid and cholesterol accumulations were
distributed throughout the entire plaque (Figure S3C). Calcium
staining localized near the media (Figure S3D). Smooth muscle
actin was prominent in areas where nanoparticles were trapped
after 24 hour in vivo circulation, as was glycosaminoglycan (Figure
S3E, F), the presence of which in this model conforms with that
described by Kolodgie et al in patient autopsy specimens [30].
However, none of these stainings suggested exact colocalization
with the fluorescent nanoparticles, such that no clear assignment of
a biophysical mechanism of trapping could be made based solely
on histopathology. Tunel staining identified evidence of apoptotic
cells in sections localized to the highly permeable plaque
endothelium, with some evidence of cellular apoptosis within
plaque intima (Figure S3G). Control rabbits were negative for
apoptosis. PECAM-1 staining revealed prominent angiogenesis
(Figure S3H) in the adventitia, but little in the intima until time
points beyond 10 months (see below).
Electron microscopy: Based on a recent provocative report by
Abela et al of cholesterol crystals penetrating the endothelial
surface of human plaques in unstable carotid artery disease [31],
we sought to confirm the presence of these features of endothelial
erosions in rabbits. Aortic specimens with obvious raised plaques
were treated according to Abela’s method to preserve the crystal
structure by dehydrating tissues with speed vac drying, and some
by the conventional ethanol dehydration method. Similar to what
they observed in human tissues [31], cholesterol crystals
penetrated the aortic endothelial surfaces of the rabbit plaques
(Figure 5A, B). Intriguingly, we also observed numerous cavitary
structures or channels literally, between and underneath the
crystal structures. As Abela pointed out, SEM images on tissues
processed by conventional ethanol dehydration destroys the crystal
structures making them unapparent, but fortuitously enabling
clear depiction of the superficial endothelial erosions (Figure 5C,
D). The similarity of these structural features in rabbit plaques to
human carotid artery samples derived from patients with acute
vascular syndromes as reported by Abela is striking. TEM images
of atherosclerotic vessels reveals the presence of endothelial foam
cells (Figure 5E) that are associated with barrier dysfunction [32].
Figure 2. Duration of cholesterol feeding determines NP plaque penetration in vivo. A: 6 hours circulation in vivo with Alexa fluor-488
labeled NP in 3 month cholesterol diet rabbit aorta showing modest intimal plaque thickening and little fluorescent signal (arrow). Note lack of green-
yellow autofluorescence in intima and + nuclear (DAPI stain). B: In vivo 6 hours circulation with identical NP in 9 month cholesterol diet rabbit aorta
indicative of marked endothelial penetration and particle trapping (arrow). C: In vivo 6 hours circulation with identical NP in 12 month cholesterol diet
rabbit aorta showing extensive NP penetration into intima (green). D: Sigmoidal fitting of fluorescence scores of aortas exposed in vivo to fluorescent
NP circulating for 2 hours (open) and 6 hours (solid) on rabbits fed with cholesterol for 0 to 419 days. The temporal dependence of plaque
permeability on the duration of hypercholesterolemia is well approximated with a sigmoidal function.
doi:10.1371/journal.pone.0026385.g002
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ing, we note that in sharp contrast to these superficial erosions
observed in Figure 5D, control rabbit aortas exhibited smooth
endothelial surfaces by SEM (Figure 5F) under all processing
conditions, reducing the likelihood of tissue processing artifacts.
These features also were not observed in adjacent segments of
apparently normal or earlier stage plaques in the cholesterol fed
rabbits. Taken together, these results suggest that endothelial
barrier disruption in atherosclerotic rabbits is structurally similar
to that in humans.
Analogy to human vascular barrier disruption
To relate these experimental findings to human atherosclerotic
disease, carotid endarterectomy specimens from 8 patients
undergoing clinically indicated vascular surgery were tested ex
vivo. Freshly harvested segments for electron microscopy were fixed
in 2.5% glutaraldehyde at 4uC for 24 hours and then speed
vacuum dried overnight as outlined in the Methods section to
permit observation of cholesterol crystals, which were similar to
those observed in the rabbit tissues and in proximity to the
disrupted endothelium (Figure 6A). Other fresh endarterectomy
specimens were pretreated briefly with human plasmin (1 mg/ml)
for 1 hour to digest residual superficial fibrin, and then incubated
with fluorescent or non-fluorescent nanoparticles for 6 hours.
Fluorescent microscopy indicated strong fluorescent signals from
intact nanoparticles trapped in the intima (Figure 6B). Fluorine
MRS confirmed that intact fluorescent nanoparticles penetrated
into the plaques (Figure 6C). Specimens treated with non-
fluorescent nanoparticles exhibited a strong
19F MRS signal, but
no fluorescent signal (data not shown). Because these thin tissue
sections for microscopy were cut from the center of the gross
endarterectomy specimen by progressive slicing after incubation
with PFC-NP, we note that the diffusion into the middle of the
processed specimen represents true penetration into the mass of
the plaque, which was devoid of adventitial microvessels.
Nanoparticles penetrate passively from the lumen side
through endothelial layer
Ex vivo control tests were performed to delineate the route of
nanoparticle permeation. Figure S4A again shows the lack of
autofluorescence in 12 month fed animal aortic segments. When
the adventitia is manual stripped from the raised plaques in lesions
Figure 3. MRI imaging and quantification of NP signal in cholesterol plaques. A: Left: 3D saggital rendering of nanoparticle signals from
aorta of 12 mo cholesterol fed rabbit after 12 hours circulation time in vivo.
19F MR image registering nanoparticle fluorine cores (color) overlaid on
1H MR image (gray) of aorta show intimal (I) location of particles trapped in thickened plaque (color) atop the medial (M) layer (gray). Particle
concentration per voxel is coded in nM (scale bar). Right: Close up of intimal layer. B:
1H,
19F and overlay MR transverse images of aortic rings with
nanoparticles trapped in intima of thickened plaque from 9 mo cholesterol fed rabbit after 2 hour circulation in vivo. Black artifacts are small air
bubbles. Note lack of
19F signal from more normal adjacent tissue sections. C: Comparison of normalized CE NP number to the endothelial surface
area between 3 month diet and .7 month diet rabbit aorta samples showing 10 fold greater accumulation in older plaques.
doi:10.1371/journal.pone.0026385.g003
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mimick the situation for the carotid endarterectomy specimens in
patients , and then incubated for 6 hours prior to fixing and
sectioning, a strong fluorescent signal is observed in the intima but
not the media, suggesting that the nanoparticles readily can gain
access from the luminal side, and not necessarily through vasa
vasorum that might originate from the adventitia (Figure S4B).
To demonstrate that intimal permeation occurs by passive
diffusion, sodium azide pretreatment of freshly excised plaques for
one hour was employed to inhibit active cellular processes, which
did not prevent nanoparticle penetration and trapping (Figure
S4C). Furthermore, similar tests on formalin fixed aortic
specimens demonstrated similar passive plaque penetration and
trapping (data not shown). These tests indicate that active cell
internalization and trapping is not required. Indeed, the PFC-NP
appear to be distributed widely throughout all regions of the
plaque in no direct association with any specific cell type, although
some uptake cannot be ruled out but generally would not be
expected after only an hour or so of in vivo circulation.
To further assess any potential relationship of nanoparticle
permeation to plaque angiogenesis, PECAM-1 staining was
performed in a random sampling of 24 aortic sections from 0, 3,
9 and 12 month fed rabbits (n=3 rabbits each). Quantitative
angiogenesis scores for 0, 3, 9, and 12 month fed rabbits were:
intima: 060, 060, 0.6761.2 and 361; and for adventitia: 560.7,
9.765.9, 7.264.6 and 4.361.5. Thus, the extent of neovascu-
lature in the adventitia was considerable at all time points, but
minimal in the intima until the later time periods. Because the NP
penetration was maximal by 7 months at a time when intimal
neovasculature was not well developed, and because NP
penetration at 3 months was minimal at a time when adventitial
neovasculature was maximized, NP permeation into the intima
does not require intact blood circulation via plaque neovascu-
lature. Taken together with the in vitro passive diffusion data in
intact and adventitia-stripped rabbit aorta and in human
specimens devoid of adventitia, it is reasonable to conclude that
lumenal entry through disrupted endothelium predominates.
To define the severity of the barrier disruption in terms of size
exclusion, we expanded the range of particle sizes and utilized
selected dragon green-labeled polymer beads (53 nm and 2 um)
on segments of 12 month diet rabbit aortas in 6 hour incubations
(Figure S5). The smallest particles rendered a diffuse background
staining extending to near the base of the plaque, while the larger
2 um particles were confined mostly to the more superficial aspects
of the plaque. The PFC-NP penetration was intermediate to that
of the smaller and larger structures, with some of the larger
particles apparently distinguishable individually.
Discussion
A principal physiological function of the vascular endothelium is
to regulate trafficking of nutrients, fluids, signaling molecules, cells
and such to and from the luminal space to the interstitial and
cellular milieu of various organs and tissues. Yet, the mechanisms
responsible for breakdown of this important barrier related to its
timing, severity, and functional consequences remain poorly
defined and virtually undetectable in vivo with any sensitive
markers of endothelial disruption. Unfortunately, most athero-
thrombotic events occur without premonitory warning signs or
symptoms and more than half of heart attack victims die suddenly
without prior symptoms, involving an estimated prevalence of over
50 million such potentially ‘‘vulnerable’’ patients in America
Figure 4. Fluorescence microscopy of rabbit aorta segments after ex vivo NP incubation for different times. A, B: 12 month cholesterol
diet rabbit incubated with Alexa Fluor 488-labeled NP (green) for 15 minutes and 6 hours, showing progressively deeper penetration into intimal
plaque region. Media shows elastin autofluorescence (yellow-green) only. Blue=nuclear stain C: 3 month cholesterol diet rabbit aorta incubated for
6 hours with Alexa Fluor 488-labeled NP showing minimal plaque thickening and only minor particle accumulation at endothelial surface. D:
‘‘Fluorescence score’’ of ex vivo NP-treated 12-month diet rabbit aorta segments incubated for different times, confirming greater penetration with
longer NP exposure times. The exponential fit to the data indicates an asymptotic increase in penetration with little additional diffusion beyond
2 hour incubations.
doi:10.1371/journal.pone.0026385.g004
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aortic endothelium of 12 month diet rabbit aorta demonstrating extensive superficial coating with crystalline structures (arrow) consistent with
cholesterol that were not observed in standard ethanol dried preparations and similar to observations in human carotid endarterectomy samples
made by Abela et al (see text). B: SEM images of speed vacuum dried cholesterol crystal around cavitary structure (*). C: Traditional dehydrated SEM
image of cavitary structures (*) penetrating into subendothelial regions and surrounded by cholesterol crystals. D: Lower magnification SEM image
with multiple endothelial erosions (arrow). E: TEM of endothelial foam cells (arrow) in cholesterol fed rabbit aorta sample. F: SEM image of normal
aortic endothelium from regular diet rabbit for comparison.
doi:10.1371/journal.pone.0026385.g005
Figure 6. SEM, fluorescence microscopy and MRS of human carotid endarterectomy specimen. A: SEM image of intimal subendothelial
cholesterol crystals in carotid endarterectomy tissue. (scale bar=50 um) B: Fluorescence microscopy of human carotid endarterectomy specimen
(fresh) incubated ex vivo with Alexa Fluor-488 labeled NP (green). Lu: lumen; I: intima; M: media. (scale bar=500 um) C:
19F MR spectroscopy of
human plaque segment indicating a strong signal and the presence of trapped CE NP in plaque. (ppm: part per million). PFOB standard signal from
co-registered control sample is for NP calibration.
doi:10.1371/journal.pone.0026385.g006
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operational definition of vascular barrier disruption based not simply
on histopathology but on a quantitative diffusion-based method-
ology applied; 2) an animal model for endothelial barrier
disruption that is progressive and appears to mimic aspects of
human disease; and 3) a path toward an image-based method for
evaluating endothelial barrier disruption that harbors clinical
translational potential with the use of MRI-visible nanoparticles.
Mechanistic implications of endothelial barrier disruption
The present report describes numerous structural and function-
al features of experimental endothelial barrier disruption that
allows rapid penetration of nanoparticles, even up to micron size,
far into the plaque intima both in vivo and ex vivo. These
nanoparticles eventually are trapped and remain stably situated
for at least 24 hours. Entry occurs by passive diffusion, and
metabolic energy is not required, as shown by the in vitro
incubations with azide pretreatment and in fixed tissues that show
a similar appearance to the in vivo nanoparticle distributions. Thus,
although in vivo convection might also facilitate entry, there is no
requirement for cell based receptor-mediated binding of nano-
particles to permit plaque uptake.
The observed plaque surface erosions are associated with deep
channel-like structures that could provide access to the plaque
interior with dimensions that admit the larger sized (up to 2
micron) particles but not apparently red blood cells, since none
were observed. The distribution of these erosions is heterogeneous
and associated with cholesterol crystals penetrating the endothe-
lium as has been reported for unstable human plaques [31]. In
fact, the geometry is reminiscent of a spongiform complex, the
surface area of which should be enormous relative to the surface
area of the local plaque itself, offering significant potential for
interaction with blood-borne molecular and formed elements of
the clotting cascade. In contrast, relatively intact barrier function is
observed in more normal appearing adjoining segments where
nanoparticles are excluded from the intima, and severe plaque is
not evident.
The state of endothelial disruption described in the current
report might hypothetically represent an analogue of the advanced
form of profound endothelial barrier disruption associated with the
onset of plaque disruption in human disease. The temporal
transition between minimal and severe barrier damage as detected
by these types of nanoparticles occurs at some point between 3 and
7–8 months. The sigmoidal relationship in Figure 2 suggests a
critical period during which the endothelial barrier deteriorates
and allows passage of these larger particulates, whereas an
exponential fit might suggest a more gradual increase in
permeability. Which scenario might be more applicable in patients
is speculative.
At this disease stage, based on the present data, it should be
advantageous to utilize larger nontargeted semipermeant nano-
particulates (e.g., 150–300 nm) that normally would not be
expected to penetrate an intact or minimally disturbed endothe-
lium to depict the severity of barrier disruption, and even to image
it noninvasively with various molecular imaging approaches that
are now being developed for clinical use [23,24,25,35,36].
Although much prior work has emerged for defining leaky
vasculature in angiogenesis in cancer and cardiovascular disease
with the use of highly permeable paramagnetic contrast agents
that are used in standard MRI angiography, many feel that the
appearance of these agents represent transport mostly across the
plaque or tumor neovasculature [37,38,39,40,41,42,43]. However,
if the endothelial barrier is disrupted it is possible that both
avenues for contrast egress would exist and specific demonstration
of luminal endothelial barrier disruption would not be possible
with such small ‘‘extracellular’’ agents, but perhaps only with
semipermeant larger nanostructures that also might permit
quantification. In any event, the ability to quantify the signal
based on
19F MRI/MRS could yield a solid metric for assessing
the progression of disease with translatable imaging approaches.
It seems reasonable to infer that this model evolves in part as a
rapid manifestation of cumulative cholesterol-related damage to
the vascular endothelium, and thus barrier disruption might
respond favorably to or be prevented by lipid lowering as
suggested previously by others [44,45,46]. If so, the longer term
feeding strategy employed here could represent a suitable
experimental model of longstanding human disease demonstrable
by its cholesterol crystal laden surfaces, endothelial apoptosis, and
erosions. In focusing on the pathophysiological deterioration of the
endothelium, new therapeutic targets emerge, such that if
endothelial senescence could be mitigated as suggested by others
[47,48], disease progression might be slowed and the results
monitored over time. At a minimum, such approaches may serve
as useful tools for quantitative staging of the severity and
progression of endothelial barrier disruption, and for defining
the role of nanotechnologies for in vivo diagnostic imaging and
therapy.
Limitations
Although the short term NZW rabbit model of atherosclerosis is
often considered as a type of storage disease rather than a model of
complex human atherosclerosis, it is well accepted as a
fundamental workhorse for experimental studies in numerous
laboratories. Most of the data from rabbit models reported in the
literature are acquired under conditions of shorter term (3–6
months) experiments, but these were not pursued as models of
barrier disruption [49]. Ironically in our example, the longer term
feeding and high cholesterol levels resulted in structural and
functional analogues of human disease that created advanced
endothelial barrier disruption. This strategy appears to compress
the time frame over which severe endothelial damage emerges to
less than a year (,3–7 months), whereas in humans decades might
be needed to produce the same extent of barrier disturbance.
Due to stringent preparation requirements for fluorescence
imaging and accurate MRI/MRS quantification, we chose not to
assess these distinct signals in the same aortic tissue segments.
However, as both the fluorescence scores and the
19F signatures
are unique with no obscuring background and thus definitive for
the presence of PFC-NP, it is clear that in all aortic segments
examined with either method that permeability in raised plaque
regions was profoundly altered regardless of location, indicative of
widespread barrier disruption as a function of long term
cholesterol elevation. Although the development of robust in vivo
imaging and spectroscopy was beyond the scope of the present
investigation, these are subjects of future clinical investigation (see
below).
Clinical implications
The current technical advances point to several translational
opportunities. The
19F MRI/MRS signatures are provocative
because they are quantitative, exhibit no background single like
1H
nuclei which are omnipresent, and manifest unique spectral
signatures [36]. These types of particles have proven safe for
systemic use in clinical trials as blood substitutes at .106 the
present dose [50]. Clinical imaging solutions already exist for these
and other types of particles [36], but assessment of their diagnostic
utility for endothelial barrier disruption will require thorough
testing in vivo in clinical trials. Indeed, such a trial
19F PFC-NP for
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MRI/MRS has recently received IND approval by the FDA
(#108,320). We propose that if this approach can identify and
track the development of progressive vascular barrier dysfunction,
it then could be tested for its predictive capacity and for following
therapy designed to heal unstable or vulnerable plaques.
Methods
All animal procedures were approved by the Washington
University Animal Studies Committee (Protocol number: 2006
0145). For human endarterectomy tissues experiments, written
consent was obtained from all patients undergoing clinically
indicated surgical procedures, which included the use of excised
deidentified tissue samples for research purposes. A protocol for
the study entitled ‘Molecular Imaging of Cardiovascular Tissues’
was approved by Washington University Human Studies Institu-
tional Review Board (HRPO# 09-0436).
Animal model
Twenty-seven NZW rabbits were fed with a high cholesterol
diet for 3–14 months (Modified Rabbit LabDietH HF 5326 with
0.25% Cholesterol, Product #9344, TestDiet, Richmond IN).
Serum total cholesterol levels were monitored periodically (Barnes-
Jewish Hospital Clinical Pathology Laboratory). Control animals
(n=3) were fed with normal chow (Table S1). In vivo nanoparticle
circulation was performed on 20 rabbits. Rabbit aortas were
removed from the arch region beyond the left subclavian artery
down to the level of the diaphragm (Figure 1A). Systematic
evaluation of similar segments among all animals was performed
from upper segments in order of sections for fluorescence
microscopy and histology (1 cm), electron microscopy (0.5 cm),
and lower segments for MRI/MRS and whole mount fluorescence
imaging (IVIS) as shown in Figure 1A. Fluorescent nontargeted
PFC-NP comprising CE cores developed originally for in vivo
molecular imaging [24] (Figure 1B top left) were administered
intravenously (1 ml/kg) and allowed to circulate for selected times
ranging from 1–24 hours prior to aorta excision. The nominal
particle diameter was 251.863.6 nm and polydispersity was
0.19360.003 as measured by dynamic light scattering.
Figure 1B bottom depicts the structure of the nanoparticles
used. At selected time points, animals were euthanized and aortas
were excised for further analysis.
Ten additional rabbits were used for in vitro confirmation of
nanoparticle permeation of plaque (Table S1). Freshly excised
rabbit aortic sections (n=30, open lumen, 1 cm long) were
incubated with fluorescently labeled PFC nanoparticles mixed
with either rabbit blood or acellular media for 15 min to 6 hours
to assess the time dependence of treatment. In some cases, aortic
sections (n=3) were first exposed to 5 ug/ml sodium azide [51] for
1 hour to inhibit active cellular processes. Tissue sections
incubated in rabbit blood without nanoparticles or incubated in
acellular medium with plain NP were used as negative control
(n=4). To examine a wider range of sizes for synthetic
nanostructure permeability, commercially available fluorescent
polymer particles of diameter 53 nm and 2 um (Bangs laborato-
ries, Inc) were applied in vitro as above (n=11 aortic segments from
3 rabbits with cholesterol diet for 12 months).
Nanoparticle formulation
Previously described micro-emulsification methods were em-
ployed to formulate fluorescent PFC-NP of nominal diameter
,250 nm [24,25,36]. No molecular targeting ligands were
incorporated into the PFC-NP so as to permit assessment of
passive diffusion and plaque retention. The fluorine-based particle
cores comprised either CE or PFOB depending on use.
Histology
Tissues for histological analysis were frozen in O. C.T media for
fluorescence imaging. Cryosectioning (8 mm) was performed on 20
consecutive sections from each tissue sample, and 5–6 randomly
selected sections were counterstained with DAPI for fluorescence
microscopy and image digitization. Adjacent slides were saved for
immunohistochemistry and special stainings.
Multiple images were acquired from each of the different
sections with an Olympus BX61 fluorescence microscopy image
system with Biological Suite software for microscope control and
image processing (Olympus America, Inc, Center Valley, PA),
using Color View II camera for optical image recording and
digitization, and F-View II B&W CCD camera for fluorescent
images. Images were merged from three channels of green, red,
and blue, which localized nanoparticle signals, while also
eliminating any autofluorescence, which was observed predomi-
nantly in the vessel media, and not in the intimal plaque region
under these imaging conditions. Confocal microscopy was
performed with an Olympus FV1000 microscope as noted. Whole
mount fluorescence images were acquired with a Xenogen IVIS
100 system using Living Image 3.1 software.
The intensity and intimal penetration of nanoparticle fluores-
cent signals were analyzed using NIH Image J program and
graded from 1–4, with each successive increment representing
approximately 1/4 of the entire intimal plaque depth (or, from
endothelium to internal elastic lamina) for a given plaque in a
single section.
Thus, 1=25% plaque penetration, 2=50%, and so forth. No
scoring was done for adventitia or for media because no significant
nanoparticle fluorescent signal was associated with the signals in
the same region of the plaque areas under any experimental
condition. In specific, plaques that extended at least 20% around
the lumen of the vessel were evaluated. Consensus between two
experienced reviewers was achieved in all cases.
‘‘Raised plaques’’ in this report are defined as a thickened
intimal segment of artery that protrudes perceptibly from the
normal smooth contour of the vessel extended outward into the
lumen such that an obvious discontinuity exist at the shoulder
region that departs from the otherwise smooth circumferential
contour of the vessel intima (see Figure 1C). The additional
presence of infiltrating cell nuclei stained blue (DAPI) in the
intimal plaque regions (see Figure 4) confirms the presence of
thickened intima in a raised plaque. Those areas of the arterial
section directly adjacent or even remote that are not raised plaques
were classified as grossly normal, although there may be some
degree of more diffuse intimal thickening in these areas.
Stainings with oil Red O, Alcian Blue and Von Kossa were
conducted following protocols of Laboratory Methods in Histo-
technology (published by American Registry of Pathology,
Washington, D.C.). Immunohistochemical staining for PECAM-
1, Ram-11 (Dako, JC70A and MO633), and Alpha-SMA (Sigma,
M-8421) were conducted using Vectastain ABC Kit (Vector
Laboratory). An apoptosis detection kit (Chemicon, S7100) was
used for TUNEL staining, especially for examining plaque
endothelium in a limited sampling of aortas representing 0, 3, 9,
and 12 months. For microvessel analysis, sections stained with
PECAM-1 were quantified across the entire section for intima and
adventitia separately, for a total of 24 sections and 3 rabbits from
each diet period (0, 3, 9 and 12 month). Quantitative scoring was
done by counting all stained vascular structures in each region of
interest at 2006power.
Endothelial Disruption in Advanced Aorta Plaque
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26385Freshly harvested segments for electron microscopy were fixed
in 2.5% glutaraldehyde at 4uC for 24 hours, and then half of each
sample was speed vacuum dried overnight to permit cholesterol
crystal detection according to the method of Abela et al. [31], the
other half was dehydrated using the conventional ethanol
preparation method. SEM images were acquired with Hitachi S-
2600H and FEI Nova Nano 2300. TEM samples were prepared
by core facility at biology department and images were acquired
using Zeiss 902 electron microscope.
MRI/MRS
Ex vivo
19F MRI/MRS of rabbit aorta specimens (n=34 from
10 rabbits) and human endarterectomy tissues (n=8 patients) were
performed on an 11.7T Varian INOVA imaging console using a
custom built single-turn solenoid coil (1 cm internal diameter). In
each imaging experiment,
1H spin-echo images were first acquired
to determine tissue anatomical appearance and location. Acqui-
sition parameters of
1H MRI were: TR, 1 s; TE, 14 ms; slice
thickness, 1 mm; field of view, 161c m
2; image matrix, 2566256;
in-plane resolution, 40640 mm
2; and number of signal averages, 4.
Subsequently, the resonance frequency of coil was tuned to
470 MHz for
19F spin-echo MRI at the same location. Acquisition
parameters of
19F MRI were: TR, 1 s; TE, 14 ms; field of view,
161c m
2; slice thickness, 2 mm; in-plane resolution,
0.3161.25 mm
2 for cross-section view and 0.6260.62 mm
2 for
projection view, and a scan time of 4.5 hours.
Ex vivo
19F MR spectroscopy was performed to quantify the
19F
signal from tissue trapped nanoparticles with the following
parameters: TR, 2 s; TE, 4 ms, 128 signal averages, and a scan
time of approximately 4 minutes. Briefly, a
19F reference standard
consisting 5 mL of 1% PFOB nanoparticle emulsion was placed
with each tissue sample. Quantification of CE nanoparticles was
based on the distinct
19F spectra of PFOB and CE according to the
following equation
23:
# of CE NP~k|
19F signal from CE NP in tissue
19F signal from PFOB NP in reference
|
(# of PFOB NP)
where k is a constant reflecting the ratio of
19F signal intensity
acquired from the same amount of PFOB and CE nanoparticles.
The number of CE nanoparticles in each specimen was
normalized to the endothelial surface area. We note that previous
studies comparing tissue concentrations of
19F (and PFC- NP)
measured by spectroscopy and by gas chromatography of the PFC
content have established the expected direct linear relation
between the spectroscopic fluorine signatures and PFC-NP
concentrations [27].
Supporting Information
Figure S1 Fluorescence microscopy and
19F MRI. A:
Intimal penetration of NP into aortic segment after 6 hours
circulation in vivo (Alexa Fluor 488-labeled) in 9 month cholesterol
diet rabbit aorta (green signal). Blue: DAPI nuclear stain, (scale
bar=100 um) B: Control study of nonfluorescent NP circulated for
6 hours in vivo in 9 month cholesteroldiet rabbitaorta. Notelack of
intimal fluorescent signal. Blue: DAPI nuclear stain. (scale
bar=100 um) C & D: Overlay of
19F (color) and
1H (gray) MR
image (‘‘en face’’ view) of the aorta tissues (same as A&B,
respectively) confirmed strong heterogeneously distributed signals
from trapped CE NP (color) in both samples. (scale bar=3 mm).
(PDF)
Figure S2 NP signals quantified by MRI/MRS. A: Whole-
mount surface fluorescence image over a grayscale coregistered
photo of thoracoabdominal aorta from 10 month cholesterol fed
rabbit after NP circulation in vivo for 1 hour (en face view). (scale
bar=10 mm) B: Local
19F (CE) MR spectroscopy of selected
segment of aorta in C. An internal PFOB standard was used to
enable quantification of CE NP shown in the chart. (scale
bar=2 mm) C: En face projection
19F MR image (color) overlaid
onto
1H MR image (gray) of opened aortic segment (same as A)
illustrates the heterogeneity of plaque and NP distribution.
Various color bars in the right illustrate different possible metrics
for NP quantification.
(PDF)
Figure S3 Light microscopy for histological staining of
aortic sections. A: H&E staining of 12 month cholesterol diet
rabbit aorta showing morphology of plaque intima. B: Ram11
staining of plaque macrophages and foam cells (brown). C: Oil red
O stain of lipids (red). D: Van Kossa staining for calcification
(black). E: Alpha-smooth muscle actin staining of smooth muscle
cells (and myofibroblasts) (purple). F: Alcian blue staining for
glycosaminoglycans (blue). G: Tunel staining manifesting endo-
thelial cell apoptosis at plaque surface and intima (arrow). H:
Pecam-1 staining with angiogenesis expressed on adventitia of 12
month cholesterol diet rabbit aorta (arrow). Lu: lumen; I: intima;
M: media; A: adventitia.
(PDF)
Figure S4 Control tests for NP penetration. A: Ex vivo CE
NP 6 hour incubation without fluorescent label in 12 month
cholesterol diet rabbit aorta showing no intimal fluorescence
signal, or autofluorescence (yellow), confirming that fluorescent
signals originate from Alexa Fluor 488 labeled NP. B: Ex vivo
6 hour incubation with Alexa Fluor 488 labeled NP in 11month
cholesterol diet rabbit aorta plaque stripped of adventitia,
demonstrating equivalent NP penetration through the endotheli-
um. C: Ex vivo 6 hour incubation with Alexa Fluor 488 labeled
NP after 1 hour azide pre-treatment in 12 month cholesterol diet
rabbit aorta does not affect the passive NP penetration and
trapping. (scale bar=100 um) Lu: Lumen.
(PDF)
Figure S5 Fluorescent microscopy for a range of
particle sizes penetrating plaque after 6 hour ex vivo
incubation. A: 53 nm diameter fluorescent polymer beads. B:
250 nm diameter CE nanoparticles labeled with Alexa Fluor 488.
C: 2 um diameter fluorescent polymer beads. (scale bar=
100 um).
(PDF)
Table S1 Experimental Subjects.
(PDF)
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